Stergios Kechagias
216 works · 15,782 citations · h-index 46
Top works
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡
- Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting
- Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: A histopathological follow-up study
- Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects
- Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study
- Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆
- Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis
- Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease
- Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression
- Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
- Phosphatidylethanol Compared with Other Blood Tests as a Biomarker of Moderate Alcohol Consumption in Healthy Volunteers: A Prospective Randomized Study
- Effect of high‐fat, high‐protein, and high‐carbohydrate meals on the pharmacokinetics of a small dose of ethanol
- Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease
- An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
- Histological progression of non‐alcoholic fatty liver disease: a critical reassessment based on liver sampling variability